{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"myelodysplastic","columns":[{"gene":"","key":"population-da6ffce63bec2eb7b971","label":"Myelodysplastic syndrome","mondoId":"MONDO:0018881","onsetQualifier":null,"originColumnKey":"MONDO:0018881/OMIM:614286","originalViews":[{"key":"MONDO:0018881/OMIM:614286","label":"Myelodysplastic syndrome","scopeLabel":"OMIM:614286","sourceScope":"Native source population. Automatically eligible unique exact-native equivalence; not clinically reviewed."}],"recordKeys":["5bfa31846f5628dc8b29319779ed3a0395b441f44c6e675847180ab74329ed86"],"recordQualifiers":{},"scopeLabel":"OMIM:614286","sourceIds":["OMIM:614286"],"sourceScope":"Native source population. Automatically eligible unique exact-native equivalence; not clinically reviewed."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-da6ffce63bec2eb7b971"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0002863"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":1,"sourceGroups":{"omim":1}},"features":[{"hpoId":"HP:0002863","label":"Myelodysplasia","primary":true}],"ledeHtml":"Myelodysplastic syndromes (MDS) are a group of blood disorders characterized by abnormal development of blood cells within the bone marrow. People with MDS have abnormally low blood cell levels (low blood counts). Signs and symptoms may include dizziness, fatigue, weakness, shortness of breath, bruising and bleeding, frequent infections, and headaches. In some people with MDS, the condition progresses to bone marrow failure or develops into acute leukemia. MDS develops when a cell with a genetic change replicates, and the resulting copies begin to predominate in the bone marrow and suppress healthy stem cells. The genetic change may result from a genetic predisposition, or from injury to the DNA caused by an exposure such as chemotherapy or radiation. In many people with MDS there is no obvious exposure or cause.","mondoId":"MONDO:0018881","node":{"canonicalSlug":"myelodysplastic","comparisons":[],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Myelodysplastic syndrome","originalSourceId":"ORPHA:52688","paragraphs":["Myelodysplastic syndromes (MDS) are a group of blood disorders characterized by abnormal development of blood cells within the bone marrow. People with MDS have abnormally low blood cell levels (low blood counts). Signs and symptoms may include dizziness, fatigue, weakness, shortness of breath, bruising and bleeding, frequent infections, and headaches. In some people with MDS, the condition progresses to bone marrow failure or develops into acute leukemia. MDS develops when a cell with a genetic change replicates, and the resulting copies begin to predominate in the bone marrow and suppress healthy stem cells. The genetic change may result from a genetic predisposition, or from injury to the DNA caused by an exposure such as chemotherapy or radiation. In many people with MDS there is no obvious exposure or cause."],"rawAttribution":"MONDO:0018881","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-25T03:39:55Z","upstream":"GARD:0007132","url":"https://rarediseases.info.nih.gov/diseases/7132"},"ownColumnKeys":["population-da6ffce63bec2eb7b971"],"publication":"published","relationships":[{"kind":"parent","label":"myeloid hemopathy","mondoId":"MONDO:0015756","slug":null},{"kind":"parent","label":"neoplastic syndrome","mondoId":"MONDO:0021058","slug":null},{"kind":"child","label":"myelodysplastic syndrome with single lineage dysplasia","mondoId":"MONDO:0005272","slug":"myelodysplastic-syndrome-with-single-lineage-dysplasia"},{"kind":"child","label":"myelodysplastic syndrome associated with isolated del(5q)","mondoId":"MONDO:0007925","slug":"5q-minus"},{"kind":"child","label":"refractory anemia with excess blasts in transformation","mondoId":"MONDO:0015692","slug":"refractory-anemia-with-excess-blasts-in-transformation"},{"kind":"child","label":"myelodysplastic syndrome with ring sideroblasts","mondoId":"MONDO:0019157","slug":"myelodysplastic-syndrome-with-ring-sideroblasts"},{"kind":"child","label":"myelodysplastic syndrome with multilineage dysplasia","mondoId":"MONDO:0019453","slug":"myelodysplastic-syndrome-with-multilineage-dysplasia"},{"kind":"child","label":"myelodysplastic syndrome with excess blasts","mondoId":"MONDO:0019454","slug":"myelodysplastic-syndrome-with-excess-blasts"},{"kind":"child","label":"familial monosomy 7 syndrome","mondoId":"MONDO:0044645","slug":"familial-monosomy-7"},{"kind":"child","label":"childhood myelodysplastic syndrome","mondoId":"MONDO:0044873","slug":"childhood-myelodysplastic"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"published"},"records":[{"frequencyKind":"reported","key":"5bfa31846f5628dc8b29319779ed3a0395b441f44c6e675847180ab74329ed86","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:614286","disease_name":"Myelodysplastic syndrome","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0002863","is_excluded":false,"label":"Myelodysplasia","onset_id":null,"reference":"OMIM:614286","source_release":"2026-06-23"},"sourceGroups":["omim"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/7132\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0018881\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>GARD:0007132</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Myelodysplastic syndromes (MDS) are a group of blood disorders characterized by abnormal development of blood cells within the bone marrow. People with MDS have abnormally low blood cell levels (low blood counts). Signs and symptoms may include dizziness, fatigue, weakness, shortness of breath, bruising and bleeding, frequent infections, and headaches. In some people with MDS, the condition progresses to bone marrow failure or develops into acute leukemia. MDS develops when a cell with a genetic change replicates, and the resulting copies begin to predominate in the bone marrow and suppress healthy stem cells. The genetic change may result from a genetic predisposition, or from injury to the DNA caused by an exposure such as chemotherapy or radiation. In many people with MDS there is no obvious exposure or cause.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/7132\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"myelodysplastic","sourceDocuments":[{"name":"GARD: Myelodysplastic syndrome","reviewed":null,"source_release":"2026-10-25T03:39:55Z","url":"https://rarediseases.info.nih.gov/diseases/7132"},{"name":"MONDO: myelodysplastic syndrome","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0018881"}],"sourceNote":"","synonyms":["dysmyelopoietic syndrome","hematopoeitic - myelodysplastic syndrome (MDS)","MDS","MDS, unclassifiable","MDS-U","myelodysplasia","myelodysplastic neoplasm","myelodysplastic syndrome","myelodysplastic syndrome, somatic","myelodysplastic syndrome, unclassifiable","myelodysplastic syndrome/neoplasm","Myelodysplastic Syndromes","myelodysplastic syndromes","oligoblastic leukaemia","oligoblastic leukemia","preleukemia","smoldering leukemia","smouldering leukaemia"],"takeawayHtml":"","title":"myelodysplastic syndrome"},"schemaVersion":1}
